AbCellera Biologics Inc (ABCL) Stock: 52-Week Performance Insights and Trading Volume

SLGG

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. AbCellera Biologics Inc’s current trading price is -42.62% away from its 52-week high, while its distance from the 52-week low is 31.70%. The stock’s price range over this period has fluctuated between $1.89 and $4.34. The company, operating within the financial sector, had a trading volume of approximately 3.45 million for the day, which was noticeably lower than the average daily share volume of 4.18 million over the last 3 months.

In terms of market performance, AbCellera Biologics Inc had a fairly uneven. The highest value for the stock in the past year was $4.34 on 05/28/24, and the lowest value was recorded at $1.89 on 04/07/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

AbCellera Biologics Inc (ABCL) has experienced a quarterly decline of -22.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 741.99M and boasts a workforce of 596 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.76, with a change in price of -0.41. Similarly, AbCellera Biologics Inc recorded 3,867,968 in trading volume during the last 100 days, posting a change of -14.14%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ABCL stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.06.

ABCL Stock Stochastic Average

Today’s raw stochastic average for AbCellera Biologics Inc over the last 50 days is 37.27%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 75.95%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 83.54% and 85.79%, respectively.

ABCL Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -15.02%.However, over the last six months, we can see a stronger performance of -13.84%. Over the last 30 days, the price of ABCL has fallen by 19.14%. And in the last five days, it has fallen by -4.23%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.